drugset / Trial / NCT06610773
HUC-MSC for Treatment of High-risk HPV Infection
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the safety and initial effectiveness of human umbilical cord mesenchymal stem cells in HPV clearance.
Timeline
- Start
- 2024-03-01
- Primary completion
- 2025-09-10
- Completion
- 2026-09-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 1 cells/kg | Intravenous |